Bridging the Gaps

New Directions and Practice Impacting Recommendations in Multiple Sclerosis
Faculty presenters: Erin Longbrake, MD, PhD (Meeting Chair and Publication Editor); Stephen Krieger, MD; Carrie M. Hersh, DO, MSc, FAAN; Jens Kuhle, MD, PhD; Pascal Sati, PhD; Robert T. Naismith, MD; Fredrik Piehl, MD; Riley Bove, MD; and Ahmed Z. Obeidat, MD.
This NeurologyLive supplement comprises 3 articles that review the evolving biological understanding of multiple sclerosis (MS) and the associated implications for treatment. The publication also explores emerging biomarkers in MS as well as the latest ideas on the use of disease-modifying therapies, including scenarios for starting, switching, or stopping immunotherapy.
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
Linking Exercise to Dopamine and Motor Performance in Parkinson Disease
2
Previewing Parkinson Disease Pipeline: Emerging Trials to Watch in 2026
3
Previewing Expected FDA Decisions in Neurology for 2026
4
Clinical Perspectives on Promising Phase 1 Data of CAPN2-Targeting Therapy AMX0114 for ALS
5
